Emphasizing the critical importance of EXPERTISE

A Broad Impact for Global Oncology
JAMA Oncology, August 8, 2019. Co-authors from International Cancer Expert Corps

Emphasizing the critical importance of EXPERTISE, the article, “A Broad Impact for Global Oncology” available online https://jamanetwork.com/journals/jamaoncology/fullarticle/2747881 emphasizes the breadth of opportunities for global oncology. The critical need for mentorship is a driving force of ICEC with the creation of a career path being essential.  The breadth of expertise required- noted on the ICEC website- creates an opportunity for many participants in all stages of their careers.

Figure 1 from the paper includes all that can be accomplished, requiring global partnerships, innovative thinking and built up Expertise.

The paper concludes: “The size and complexity of the problems present a grand challenge worthy of the best minds and transformational approaches, often requiring partnerships that have potential for common projects even among countries and neighbors who have political conflicts. How could one not want to eradicate cancer and its deleterious impact? The Figure provides the components and benefits of a systems approach that supports leading-edge science and technology but, critically, pays attention to those populations historically and currently left behind in the trailing-edge turbulence of inequality. In this way, creativity, innovation, altruism, and commitment can bring rewarding results.”

The critical need for mentorship is a driving force of ICEC with the creation of a career path being essential.  The breadth of expertise required- noted on the ICEC website- creates an opportunity for many participants in all stages of their careers.  That global health is catching on in ASTRO is seen in the International session below on the opening day of the Annual Meeting in Chicago, September 15, 2019.

International Session 02 – (INTERACTIVE) Fighting Cancer Globally

Sunday, September 15, 2019:  1:15-2:30 Room W172

Presentations:
1:15 PM – 1:25 PM

Introduction
Speaker: C. Norman Coleman, MD, FASTRO –
1:25 PM – 1:35 PM

IAEA initiatives
Speaker: May Abdel-Wahab, MD, PhD, FASTRO – International Atomic Energy Agency (IAEA)
1:35 PM – 1:45 PM

ESTRO initiatives
Speaker: Ben Slotman, MD, PhD, FASTRO – VU University Medical Center
1:45 PM – 1:55 PM

UICC initiatives 
Speaker: Mary Gospodarowicz, MD, FASTRO – Princess Margaret Cancer Centre
1:55 PM – 2:05 PM

WHO initiatives
Speaker: Elena Fidarova, MD – World Health Organization (WHO)
2:05 PM – 2:15 PM

NCI Center for Global Health Initiatives
Speaker: Surbhi Grover, MD, MPH – University of Pennsylvania Health System
2:15 PM – 2:30 PM

Audience Q&A
Speaker: C. Norman Coleman, MD, FASTRO

A Broad Impact for Global Oncology

Global oncology demands attention, with approximately 9 million people dying from cancer annually. It provides an extraordinary opportunity to address the urgent need for cancer care and be a catalyst for solutions to address critical societal issues including the disruptive forces in and among countries involving the health of individuals and the planet, relationships among cultures, the digital revolution, inequality, and the sociopolitical conflict of globalism vs isolationism.  Read the article published online in JAMA Oncology

Job opportunity with the IAEA

Great opportunity to work at the IAEA! A 2-year global health position is for a Junior professional (JPO) in the Division of Human Health (NAHU) supported through the US government.   Click here for job listing. Apply through Argonne National labs.

April 30th deadline!

 

“I think the message is very simple: it’s wasteful not to invest in health”

The alarming report released by the WHO details the staggering drain that disease has on the African economy. It projects that by 2030, the loss in GDP could be almost $1.7 trillion unless ambitious goals to increase the investment in health care improvement are met. The report also highlights the large percentage (37%) that non-communicable diseases account for in this burden. The necessary shift to translate political commitments into investment is possible by implementing changes not only to treat disease but to promote good health and prevention.
Read more…

ICEC’s response to The Lancet, “Offline: Why has global health forgotten cancer?”

ICEC’s response to Richard Horton’s thoughtful commentary, “Offline: Why has global health forgotten cancer?” was published in The Lancet.

While prevention is critical, tackling cancer is about much more than just prevention. “The solution to the deficit of global cancer care is a systematic approach to build expertise, capacity, and capability using a sustainable model that recognizes the mutually beneficial links among cancer, the other non-communicable diseases, infectious diseases, and health-care systems, while also producing economic benefit”. Read more…

Developing Innovative, Robust and Affordable Medical Linear Accelerators for Challenging Environments

Motivated by stunning projections regarding the rise of cancer cases globally to 25 million cases in 2035 with 70% of those occurring in low- and middle- income countries, coupled with the paucity of access to radiotherapy treatment – an essential component of curative and palliative care – a group of individuals from the International Cancer Expert Corps (ICEC), Science and Technology Facilities Council (STFC UK), CERN and others, took on the challenge to meet the demands for cancer care focusing on the need to develop a medical linear accelerator to be used in resource-limited settings.  Read the Editorial in Clinical Oncology

Dr. C. Norman Coleman receives the the Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care

ICEC’s Senior Scientific Advisor, Dr. C. Norman Coleman, received the Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care. The award recognizes exceptional providers who are transforming cancer care.

The Stovall Award is awarded annually to individuals, organizations, or other entities who demonstrate innovation in improving cancer care for patients in America. NCCS created the Stovall Award in honor of Ellen Stovall, NCCS’ longtime CEO who passed away in 2016 due to cardiac complications from her cancer treatment.  Read more…

The fight against non-communicable disease in emerging economies

October 17, 2018

Charles Schmidt, a science writer for Nature, highlights that health-care providers in low- and middle-income countries are shifting their focus away from infections, and towards the bigger problems of diabetes and cardiovascular disease.

While cardiovascular diseases account for most NCD deaths, or 17.9 million people annually,  cancers account for (9.0 million), respiratory diseases (3.9million), and diabetes (1.6 million). These 4 groups of diseases account for over 80% of all premature NCD deaths. Read more…

HPV-related cancer rates are rising. So are vaccine rates — just not fast enough.

Cancers linked to the human papillomavirus have increased significantly over the last 15 years in the United States, with throat cancer now the most common HPV-related malignancy, the Centers for Disease Control and Prevention reported Thursday. More than 43,000 people developed HPV-associated cancer in 2015, compared with about 30,000 in 1999, the CDC said.

At the same time, the CDC said, HPV vaccination rates are rising — a trend that could eventually curb the increase in cancer cases  — But the rate is not rising fast enough, experts say. Nearly half of adolescents ages 13 to 17 in 2017 had received all the recommended doses for HPV vaccination, while two-thirds had received the first dose. Read the Washington Post article…

This is a challenge for those in Low-Income Countries LIC and Low- and Middle-Income Countries (LMIC) as well.  Gallagher, K. et al, in Vaccine, “Status of HPV vaccine introduction and barriers to country uptake” suggest that if one-dose HPV vaccination became viable, some of the significant barriers to scale-up and sustained use in LIC/LMIC may be overcome. (Perhaps the same for Upper-Income Countries?) The vaccine could prevent 90 percent of HPV-caused cancer cases every year.